NASDAQ:OKYO

Track all markets on TradingView - Prices are not updated in real time
### OKYO Pharma (OKYO) Stock Falls After HC Wainwright Lowers Price Target

OKYO Pharma (NASDAQ: OKYO) shares declined about 5.9% after HC Wainwright lowered its price target on the clinical-stage biotechnology company to $5 from $7 while maintaining its Buy rating.

The reduced price target reflects a more conservative valuation outlook despite the firm's continued positive long-term view of the company. Investors remain focused on OKYO Pharma's clinical development pipeline, with the stock's valuation largely dependent on the progress of its investigational therapies and upcoming clinical milestones.

Key factors weighing on the stock include:

* HC Wainwright lowered its price target to $5 from $7.
* The firm maintained its Buy rating.
* Investors remain focused on the company's clinical pipeline and upcoming trial milestones.
* The lower valuation target prompted a cautious market reaction despite the unchanged positive rating.

The reduced price target weighed on investor sentiment, sending OKYO Pharma shares lower during the trading session.
💬 🔗
Author
WS Investor 07-13-26